These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 92151)

  • 21. X-ray microanalysis of melanin granules of retinal pigment epithelium and choroid in hereditary copper deficient mice (macular mice).
    Mishima K; Amemiya T; Takano K
    Exp Eye Res; 1999 Jan; 68(1):59-65. PubMed ID: 9986742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of cysteinyldopa in the mature bovine eye.
    Dryja TP; Albert DM; Rosengren E; Reid TW
    Exp Eye Res; 1977 Nov; 25(5):459-64. PubMed ID: 598423
    [No Abstract]   [Full Text] [Related]  

  • 23. Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium.
    Dryja TP; O'Neil-Dryja M; Pawelek JM; Albert DM
    Invest Ophthalmol Vis Sci; 1978 Jun; 17(6):511-4. PubMed ID: 96039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of brimonidine transport in retinal pigment epithelium.
    Zhang N; Kannan R; Okamoto CT; Ryan SJ; Lee VH; Hinton DR
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):287-94. PubMed ID: 16384975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of chlorpromazine to cultured retinal pigment epithelial cells loaded with melanin.
    Basu PK; Menon IA; Persad SD; Wiltshire JD
    Lens Eye Toxic Res; 1989; 6(1-2):229-40. PubMed ID: 2488019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-S-cysteinyldopa and pigment response to UVA light.
    Tegner E; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):21-5. PubMed ID: 6191484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidation of dopa in the skin of black and albino mice.
    Carstam R; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1986; 66(5):369-74. PubMed ID: 2431571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
    Kågedal B; Gawelin AL; Pettersson A
    Anal Biochem; 1987 Aug; 165(1):167-74. PubMed ID: 3120620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugation of dopa and 5-S-cysteinyldopa with cysteine mediated by superoxide radical.
    Ito S; Fujita K
    Biochem Pharmacol; 1982 Sep; 31(18):2887-9. PubMed ID: 6291549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related melanogenesis in the eye of mice, studied by microautoradiography of 3H-methimazole, a specific marker of melanin synthesis.
    Lindquist NG; Larsson BS; Stjernschantz J; Sjöquist B
    Exp Eye Res; 1998 Sep; 67(3):259-64. PubMed ID: 9778406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of DOPA-loading on glutathione-dependent 5-S-cysteinyldopa genesis in melanoma cells in vitro.
    Mojamdar M; Ichihashi M; Mishima Y
    J Invest Dermatol; 1982 Mar; 78(3):224-6. PubMed ID: 6799583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipofuscin component A2E does not reduce antioxidant activity of DOPA-melanin.
    Dontsov AE; Koromyslova AD; Sakina NL
    Bull Exp Biol Med; 2013 Mar; 154(5):624-7. PubMed ID: 23658884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eumelanins and pheomelanins: characterization by electron spin resonance spectroscopy.
    Sealy RC; Hyde JS; Felix CC; Menon IA; Prota G
    Science; 1982 Aug; 217(4559):545-7. PubMed ID: 6283638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous redox reactions of dopaquinone and the balance between the eumelanic and phaeomelanic pathways.
    Land EJ; Riley PA
    Pigment Cell Res; 2000 Aug; 13(4):273-7. PubMed ID: 10952395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.